Unilateral lower-limb vasculopathy: A rare adverse event of CDK4/6 inhibitor in breast cancer

Kaohsiung J Med Sci. 2022 May;38(5):494-495. doi: 10.1002/kjm2.12526. Epub 2022 Mar 23.

Authors

Chih-Ching Chin¹, Jun-Ping Shiau², Chi-Wen Luo², Ming-Feng Hou²

Affiliations

¹ Department of Pathology, E-Da Hospital, Kaohsiung, Taiwan.
² Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

PMID: 35319159
DOI: 10.1002/kjm2.12526

No abstract available

Publication types

Letter

MeSH terms

Breast Neoplasms* / drug therapy
Cyclin-Dependent Kinase 4 / genetics
Cyclin-Dependent Kinase 6
Female
Humans
Protein Kinase Inhibitors / adverse effects

Substances

Protein Kinase Inhibitors
CDK4 protein, human
Cyclin-Dependent Kinase 4
Cyclin-Dependent Kinase 6